Intelligent Bio Solutions Raises Up to $15M in At-the-Market Private Placement
INBS sits 70% above its 52-week low of $1.52 on light trading volume (0.3× avg).
Summary
Intelligent Bio Solutions announced a private placement of up to $15 million to a single existing institutional investor, priced at-the-market under Nasdaq rules. The company has a market cap of roughly $7.3 million, so this raise is highly dilutive and materially larger than its existing $3.97 million ATM program. The company reported a going concern warning and a $12.4 million net loss in its recent 10-K, so this capital is likely needed to fund operations and the FDA 510(k) submission. The at-the-market pricing suggests the investor is getting shares at current market levels, which may limit immediate downside but still dilutes existing holders significantly. Watch for the final terms and any use-of-proceeds details in the upcoming 8-K.
At the time of this announcement, INBS was trading at $2.58 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.3M. The 52-week trading range was $1.52 to $24.90. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.